Catalyst OrthoScience key facts
as of Oct 2026- Developer of a shoulder replacement system designed to make orthopedic surgery less invasive and more efficient.
- Catalyst OrthoScience is valued at approximately $43.4M as of Oct 2026 (last reported valuation).
- It has raised $86.6M across 5 recorded rounds; the latest was Seed Round ($4.1M) in Jul 2025.
- Notable investors include Lateral Capital Management, Tamiami Angel Funds, RC Capital (Cincinnati), Bridge Bank, Derace Schaffer — 10 tracked in total.
- Catalyst OrthoScience has filed 7 Form Ds with the SEC since 2015, most recently Jul 2025 ($4.1M sold to 3 investors).
- Status: Privately Held (backing).
Catalyst OrthoScience's last reported valuation, Sep 2023. Nothing priced has surfaced since.
- ·Watch Catalyst OrthoScience: the Monday email on marks, rounds and moves
Catalyst OrthoScience funding rounds
5 roundsCatalyst OrthoScience valuation
Catalyst OrthoScience's last reported valuation was $43.4 million in Sep 2023. No priced round, secondary trade or fund mark has surfaced since.
How much has Catalyst OrthoScience raised?
Catalyst OrthoScience has raised $86.6 million in total; 5 of its rounds are on record, from 2016 on. The largest on record was a $4.1 million seed round in Jul 2025.
Catalyst OrthoScience has filed 7 Form Ds with the SEC since 2015, most recently in Jul 2025 ($4.1 million sold to 3 investors).
Catalyst OrthoScience investors
10 investors are on record for Catalyst OrthoScience, including Lateral Capital Management, Tamiami Angel Funds, RC Capital (Cincinnati) and Bridge Bank. The seed round in Jul 2025 drew 3 investors.
About Catalyst OrthoScience
Developer of a shoulder replacement system designed to make orthopedic surgery less invasive and more efficient. The company's system is fixed without a stem to preserve as much strong, healthy bone as possible, replacing traditional shoulder implants, which required removal of the top of the humerus so a stem could be inserted down into the bone canal, enabling patients to get access to a precisely less-invasive alternative method of shoulder implant placement.
- Sector
- Healthcare
- HQ
- Naples, FL, United States
- Founded
- 2014
- Employees
- 52
- Website
- catalystortho.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.